Global Oral Vaccines Market Research Report 2021

1 Oral Vaccines Market Overview

• 1.1 Product Overview and Scope of Oral Vaccines
• 1.2 Oral Vaccines Segment by Type
  • 1.2.1 Global Oral Vaccines Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Rotavirus Vaccine
  • 1.2.3 Cholera Vaccine
  • 1.2.4 Oral Polio Vaccine
  • 1.2.5 Others
• 1.3 Oral Vaccines Segment by Application
  • 1.3.1 Oral Vaccines Sales Comparison by Application: (2021-2027)
  • 1.3.2 Public
  • 1.3.3 Private
• 1.4 Global Oral Vaccines Market Size Estimates and Forecasts
  • 1.4.1 Global Oral Vaccines Revenue 2016-2027
  • 1.4.2 Global Oral Vaccines Sales 2016-2027
  • 1.4.3 Oral Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027

2 Oral Vaccines Market Competition by Manufacturers

• 2.1 Global Oral Vaccines Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Oral Vaccines Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Oral Vaccines Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Oral Vaccines Manufacturing Sites, Area Served, Product Type
• 2.5 Oral Vaccines Market Competitive Situation and Trends
  • 2.5.1 Oral Vaccines Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Oral Vaccines Players Market Share by Revenue
  • 2.5.3 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oral Vaccines Retrospective Market Scenario by Region

• 3.1 Global Oral Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Oral Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Oral Vaccines Market Facts & Figures by Country
  • 3.3.1 North America Oral Vaccines Sales by Country
  • 3.3.2 North America Oral Vaccines Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Oral Vaccines Market Facts & Figures by Country
  • 3.4.1 Europe Oral Vaccines Sales by Country
  • 3.4.2 Europe Oral Vaccines Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Oral Vaccines Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Oral Vaccines Sales by Region
  • 3.5.2 Asia Pacific Oral Vaccines Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Oral Vaccines Market Facts & Figures by Country
  • 3.6.1 Latin America Oral Vaccines Sales by Country
  • 3.6.2 Latin America Oral Vaccines Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Oral Vaccines Sales by Country
  • 3.7.2 Middle East and Africa Oral Vaccines Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Oral Vaccines Historic Market Analysis by Type

• 4.1 Global Oral Vaccines Sales Market Share by Type (2016-2021)
• 4.2 Global Oral Vaccines Revenue Market Share by Type (2016-2021)
• 4.3 Global Oral Vaccines Price by Type (2016-2021)

5 Global Oral Vaccines Historic Market Analysis by Application

• 5.1 Global Oral Vaccines Sales Market Share by Application (2016-2021)
• 5.2 Global Oral Vaccines Revenue Market Share by Application (2016-2021)
• 5.3 Global Oral Vaccines Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Merck
  • 6.1.1 Merck Corporation Information
  • 6.1.2 Merck Description and Business Overview
  • 6.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Merck Product Portfolio
  • 6.1.5 Merck Recent Developments/Updates
• 6.2 GSK
  • 6.2.1 GSK Corporation Information
  • 6.2.2 GSK Description and Business Overview
  • 6.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 GSK Product Portfolio
  • 6.2.5 GSK Recent Developments/Updates
• 6.3 Sanofi
  • 6.3.1 Sanofi Corporation Information
  • 6.3.2 Sanofi Description and Business Overview
  • 6.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Sanofi Product Portfolio
  • 6.3.5 Sanofi Recent Developments/Updates
• 6.4 Lanzhou Institute
  • 6.4.1 Lanzhou Institute Corporation Information
  • 6.4.2 Lanzhou Institute Description and Business Overview
  • 6.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Lanzhou Institute Product Portfolio
  • 6.4.5 Lanzhou Institute Recent Developments/Updates
• 6.5 Serum Institute
  • 6.5.1 Serum Institute Corporation Information
  • 6.5.2 Serum Institute Description and Business Overview
  • 6.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Serum Institute Product Portfolio
  • 6.5.5 Serum Institute Recent Developments/Updates
• 6.6 Valneva
  • 6.6.1 Valneva Corporation Information
  • 6.6.2 Valneva Description and Business Overview
  • 6.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Valneva Product Portfolio
  • 6.6.5 Valneva Recent Developments/Updates
• 6.7 Shanghai United Cell
  • 6.6.1 Shanghai United Cell Corporation Information
  • 6.6.2 Shanghai United Cell Description and Business Overview
  • 6.6.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Shanghai United Cell Product Portfolio
  • 6.7.5 Shanghai United Cell Recent Developments/Updates
• 6.8 Bibcol
  • 6.8.1 Bibcol Corporation Information
  • 6.8.2 Bibcol Description and Business Overview
  • 6.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Bibcol Product Portfolio
  • 6.8.5 Bibcol Recent Developments/Updates
• 6.9 PaxVax
  • 6.9.1 PaxVax Corporation Information
  • 6.9.2 PaxVax Description and Business Overview
  • 6.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 PaxVax Product Portfolio
  • 6.9.5 PaxVax Recent Developments/Updates
• 6.10 Vabiotech
  • 6.10.1 Vabiotech Corporation Information
  • 6.10.2 Vabiotech Description and Business Overview
  • 6.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Vabiotech Product Portfolio
  • 6.10.5 Vabiotech Recent Developments/Updates
• 6.11 Tiantan Biological
  • 6.11.1 Tiantan Biological Corporation Information
  • 6.11.2 Tiantan Biological Oral Vaccines Description and Business Overview
  • 6.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Tiantan Biological Product Portfolio
  • 6.11.5 Tiantan Biological Recent Developments/Updates
• 6.12 EuBiologics
  • 6.12.1 EuBiologics Corporation Information
  • 6.12.2 EuBiologics Oral Vaccines Description and Business Overview
  • 6.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 EuBiologics Product Portfolio
  • 6.12.5 EuBiologics Recent Developments/Updates
• 6.13 Panacea Biotec Ltd
  • 6.13.1 Panacea Biotec Ltd Corporation Information
  • 6.13.2 Panacea Biotec Ltd Oral Vaccines Description and Business Overview
  • 6.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Panacea Biotec Ltd Product Portfolio
  • 6.13.5 Panacea Biotec Ltd Recent Developments/Updates
• 6.14 Bio-Med
  • 6.14.1 Bio-Med Corporation Information
  • 6.14.2 Bio-Med Oral Vaccines Description and Business Overview
  • 6.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Bio-Med Product Portfolio
  • 6.14.5 Bio-Med Recent Developments/Updates
• 6.15 Halfkin Bio-Pharmaceuticals
  • 6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
  • 6.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Description and Business Overview
  • 6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Halfkin Bio-Pharmaceuticals Product Portfolio
  • 6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates

7 Oral Vaccines Manufacturing Cost Analysis

• 7.1 Oral Vaccines Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Oral Vaccines
• 7.4 Oral Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Oral Vaccines Distributors List
• 8.3 Oral Vaccines Customers

9 Oral Vaccines Market Dynamics

• 9.1 Oral Vaccines Industry Trends
• 9.2 Oral Vaccines Growth Drivers
• 9.3 Oral Vaccines Market Challenges
• 9.4 Oral Vaccines Market Restraints

10 Global Market Forecast

• 10.1 Oral Vaccines Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Oral Vaccines by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Oral Vaccines by Type (2022-2027)
• 10.2 Oral Vaccines Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Oral Vaccines by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Oral Vaccines by Application (2022-2027)
• 10.3 Oral Vaccines Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Oral Vaccines by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Oral Vaccines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List